Discover
BCTX
BriaCell Therapeutics Corp.
3.41
1 x 3.41
3 x 3.45
bid
ask
+
0.02
0.59%
12:31 PM
timesize
| Ytd | -52.04% | |
| 1y | -50.58% |
3.41
day range
3.50
2.60
52 week range
14.68
| Open | 3.46 | Prev Close | 3.39 | Low | 3.41 | High | 3.50 | Mkt Cap | 29.67M |
| Vol | 40.81K | Avg Vol | 202.90K | EPS | -18.41 | P/E | -0.19 | Forward P/E | -1.38 |
| Beta | 1.14 | Short Ratio | 0.77 | Inst. Own | 4.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 06-16 | 50-d Avg | 3.35 | 200-d Avg | 5.51 | 1yr Est | 15.00 |
| Income Statement | |||
| Operating Expenses | 7.62M | ||
| Research and Development Expense | 5.97M | ||
| Selling, General and Administrative Expense | 1.65M | ||
| Operating Income | -7.62M | ||
| Interest Expense | -186.97K | ||
| Net Income | -7.24M | ||
| Net Income Common Stock | -7.24M | ||
| Net Income Common Stock (USD) | -7.24M | ||
| Consolidated Income | -7.31M | ||
| Net Income to Non-Controlling Interests | -72.55K | ||
| Earnings per Basic Share | -0.99 | ||
| Earnings per Basic Share (USD) | -0.99 | ||
| Earnings per Diluted Share | -0.99 | ||
| Earning Before Interest & Taxes (EBIT) | -7.42M | ||
| Earning Before Interest & Taxes (USD) | -7.42M | ||
| Weighted Average Shares | 7.25M | ||
| Weighted Average Shares Diluted | 7.25M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.88M | ||
| Cash and Equivalents (USD) | 6.88M | ||
| Investments | 16.68M | ||
| Investments Current | 15.92M | ||
| Investments Non-Current | 750.98K | ||
| Current Assets | 25.39M | ||
| Property, Plant & Equipment Net | 349.00K | ||
| Total Assets | 27.07M | ||
| Current Liabilities | 3.59M | ||
| Total Liabilities | 3.66M | ||
| Accumulated Retained Earnings (Deficit) | -134.34M | ||
| Accumulated Other Comprehensive Income | -138.68K | ||
| Shareholders Equity | 23.41M | ||
| Shareholders Equity (USD) | 23.41M | ||
| Assets Non-Current | 1.68M | ||
| Goodwill and Intangible Assets | 173.07K | ||
| Liabilities Non-Current | 71.85K | ||
| Trade and Non-Trade Payables | 2.17M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 33.01K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -23.02M | ||
| Capital Expenditure | -127.05K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -95.00K | ||
| Net Cash Flow from Investing | -16.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -15.78M | ||
| Net Cash Flow from Operations | -7.02M | ||
| Share Based Compensation | 432.21K | ||